Quarterly Result12 May 2026, 04:19 pm
Neuland Labs: FY26 Results, ₹34 Dividend & Capacity Expansion
AI Summary
Neuland Laboratories Ltd has announced its audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹34 per equity share (340%) on a face value of ₹10. The company's Board of Directors also approved the appointment of Dr. Mauricio Futran as an Additional Director (Non-Executive Non-Independent) effective May 12, 2026, subject to shareholder approval. Furthermore, the company approved convening the 42nd AGM on August 4, 2026, with a record date of July 24, 2026, for dividend eligibility. Neuland Labs plans to enhance capacity at its Unit 1 by 120.5 KL with an investment of ₹143.4 crores, financed through internal accruals and borrowings.
Key Highlights
- Neuland Labs recommends a final dividend of ₹34 per share (340%) for FY26.
- Dr. Mauricio Futran appointed as an Additional Non-Executive Non-Independent Director.
- 42nd AGM scheduled for August 4, 2026; record date fixed as July 24, 2026.
- Capacity expansion of 120.5 KL planned at Unit 1 with ₹143.4 crore investment.
- Audited financial results (standalone & consolidated) for FY26 approved with unmodified opinion.